TPG Capital’s Majority Investment in Confluent Medical Technologies

Latham & Watkins represented TPG Capital in the transaction.Confluent Medical Technologies (Confluent), a leading materials science, development, and manufacturing partner to medical device manufacturers, has announced…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here